ANGLE plc (LON:AGL – Get Free Report) shot up 6.2% during trading on Tuesday . The stock traded as high as GBX 13.14 ($0.17) and last traded at GBX 13.02 ($0.16). 318,303 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 1,646,051 shares. The stock had previously closed at GBX 12.25 ($0.15).
Analyst Ratings Changes
Separately, Berenberg Bank reissued a “buy” rating and set a GBX 40 ($0.50) price target on shares of ANGLE in a research report on Wednesday, January 29th.
Get Our Latest Stock Analysis on ANGLE
ANGLE Stock Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Featured Articles
- Five stocks we like better than ANGLE
- ESG Stocks, What Investors Should Know
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Why Invest in 5G? How to Invest in 5G Stocks
- Price Targets on NVIDIA Rise in Front of Earnings
- High Flyers: 3 Natural Gas Stocks for March 2022
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.